{
    "2021-01-20": [
        [
            {
                "time": "",
                "original_text": "药房“湘军”风头正劲，连锁药店迎来发展机遇期",
                "features": {
                    "keywords": [
                        "药房",
                        "湘军",
                        "连锁药店",
                        "发展机遇"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "零售"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药股表现强势，“两定”新规将施行，利好龙头连锁药店",
                "features": {
                    "keywords": [
                        "医药股",
                        "两定新规",
                        "龙头连锁药店"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业报告：中外新冠疫苗PK 孰优孰劣？",
                "features": {
                    "keywords": [
                        "医药生物",
                        "新冠疫苗",
                        "中外对比"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "52只股北向资金持有流通盘的比例超10%",
                "features": {
                    "keywords": [
                        "北向资金",
                        "持股比例"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "全市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【医药】自上而下甄选赛道，业绩和估值斟酌个股――医药行业周报——中性",
                "features": {
                    "keywords": [
                        "医药",
                        "自上而下",
                        "赛道",
                        "业绩",
                        "估值"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}